While last week was an epic week of quarterly earnings reporting, this week will see more companies releasing their numbers. The following is a quick look at five companies who will be releasing reports at the end of trading Tuesday, 30 April, 2013.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX):
Welcome to our latest issue of issue of ValueWalk’s hedge fund update. Below subscribers can find an excerpt in text and the full issue in PDF format. Please send us your feedback! Featuring hedge fund assets near $4 trillion, hedge funds slash their exposure to the big five tech companies, and Rokos Capital's worst-ever loss. Read More
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases.Vertex has popped big recently on new promising data for patients diagnosed with cystic fibrosis, including a one day gain of 60 percent. That doesn’t mean that Vertex is a one trick pony. They have two Hepatitis C drugs currently in clinical testing.
Analysts predict a loss of $0.16 per share after the company saw a profit of $0.41 a year ago. The consensus estimate has narrowed from a loss of $0.17 over the past month. Three months ago the consensus estimate put the loss at $0.19. For the fiscal year, analysts are projecting a loss of $0.97 per share. After being $438.7 million a year ago, analysts project revenue to drop 29.9 percent year-over-year to $307.7 million for the quarter. For the year, revenue is projected to come in at $1.16 billion.
Despite these seemingly gloomy numbers 75 percent of analysts rate Vertex as a “buy” compared to just over 50 percent for its closest competitors.
Verisk Analytics, Inc. (NASDAQ:VRSK):
Verisk Analytics, Inc. (NASDAQ:VRSK) provides proprietary data, analytics methods, and embedded decision support solutions for detecting fraud in property and casualty (P&C) insurance, financial, and healthcare industries primarily in the United States.
The consensus estimate has Verisk Analytics, Inc. (NASDAQ:VRSK) announcing a profit of $0.53 per share, an increase of 12.8 percent from a year ago when Verisk reported a profit of $0.47 per share. For the fiscal year analysts are expecting earnings of $2.33 per share compared to last year’s $2.10 per share. Earnings per share expectations have not moved in the last 90 days.
Revenue is expected to come in at $403.26 up 16.4 percent from the year-over-year $346.5 million. Analysts expect that revenue for the fiscal year will reach $1.72 billion compared to last year’s revenue of $1.53. This represents a growth of 12.3 percent for the year.
Leap Wireless International, Inc. (NASDAQ:LEAP):
Leap Wireless International, Inc. (NASDAQ:LEAP), together with its subsidiaries, provides digital wireless services under the Cricket brand name in the United States. Following a downgrade today from JPMorgan Chase & Co. (NYSE:JPM), Leap Wireless has lost nearly 10 percent of its share price and presently represents one of the largest share losses as a percentage on the NASDAQ today.
Analysts are expecting Leap Wireless International, Inc. (NASDAQ:LEAP) to post a loss of $1.26 per share when they announce tomorrow. This is a very slight improvement year-over-year from when they posted losses of $1.28 per share. This number has slid from the projected loss of $1.21 just 30 days ago. For the fiscal year, analysts expect Leap Wireless to show a loss of $4.64 per share compared to a loss less than half of that last year when they delivered a loss of just $2.21.
Analysts expect quarterly revenue of $735.66 million down nearly 11 percent year-over-year when they saw revenues of $825.62 million.
Great things are not expected at Leap Wireless any time soon. This was made abundantly clear today when in a note to clients, analyst Philip Cusick cited “weakening subscriber trends, increasing competition, and challenging cash flow” at the pre-paid wireless carrier. “We expect T-Mobile to launch its MetroPCS Communications Inc (NYSE:PCS) brand across a number of Leap markets before the end of the year, and most of the footprint by the end of 2014.”
Jamba, Inc. (NASDAQ:JMBA):
Analysts have gotten more optimistic about Jamba’s earnings prospects in recent months, having cut their initial loss estimates for the just-ended quarter in half and raised their consensus for future full-year 2014 earnings by $0.02 per share. The stock has responded in kind with a 6 percent jump since late January.
The consensus estimate suggests that Jamba, Inc. (NASDAQ:JMBA) will report a loss of $0.02 per share compared to a year-over-year loss of $0.03. The consensus numbers buy Jamba’s revenue at $54.1 million which represents a 2 percent growth from the year-over-year quarter.
While many companies see the bulk of their sales in the winter and fall months, this is not the case with Jamba Juice whose sales of cold beverages are a tough sell in much of the country as winter sets in each year.
Genworth Financial Inc (NYSE:GNW):
Genworth Financial Inc (NYSE:GNW), a financial services company, provides insurance, wealth management, investment, and financial solutions in the United States and internationally. Last month saw Barron’s write favorably about Genworth, the editorial cites a well-respected hedge fund manager who states, “this stock is a solid buy, trading at such a ridiculously low level with solid assets that more than make up for potential losses.” Last week also billionaire John Paulson and loud-mouth Jim Cramer issued buy recommendations for Genworth.
Analysts expect Genworth Financial Inc (NYSE:GNW) to report earnings of $0.27 per share tomorrow down from $0.31 just 30 days ago. However, in the year-over-year quarter, Genworth only saw earnings of $0.06.
Revenue is expected to come in at $2.49 billion, up 4.1% from a year ago when it reported revenues of $2.39 billion for the same quarter. Fiscal year revenue is anticipated at $10.01 billion compared to $10.00 billion a year ago, a moderate gain at best.